FDA Inspection 998978 — Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group (Ningxia) Pharmaceutical Co., Ltd. on Jan 13, 2017 in Shizuishan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 13, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Shizuishan (China)